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Systematic review and meta-analysis of patient
reported outcomes for nurse-led models of
survivorship care for adult cancer patients

Abstract
Purpose
This systematic review aimed to determine the effectiveness of nurse-led cancer survivorship care, compared with existing
models of care, on patient reported outcomes for cancer survivors.
Methods
Randomised and non-randomised controlled trials and controlled before-after studies published in English between 1 January
2007 and 28 July 2017 were identified in bibliographic databases including Medline, Pubmed and PsychINFO. Included studies
described nurse-led cancer care after treatment to adults (age ≥18 years) <2 years post treatment completion. Risk of bias was
assessed using Joanna Briggs Institute’s tools and meta-analysis was undertaken.
Results
Twenty one publications were included describing 15 tumour-specific trials involving 3278 survivors of breast (n=5),
gynecological (n=3), head and neck (n=2), colorectal (n=2), upper gastrointestinal (n=2) and prostate (n=1) cancers. Seven trials
reported quality of life (QoL) using the EORTC QLQ-C30; participants receiving nurse-led care (4-6 months) had better cognitive
(4 trials, 463 participants; mean difference [MD]=4.04 [95% CI, 0.59 to 7.50]; p=0.02) and social functioning (4 trials, 463
participants; MD=3.06 [0.14 to 5.97]; p=0.04) but worse appetite loss (3 trials, 354 participants; MD=4.43 [0.08 to 8.78]; p=0.05).
After intervention completion, intervention participants had reduced fatigue (4 trials, 647 participants; MD=-4.45 [-7.93 to -0.97];
p=0.01).
Conclusion
This systematic review synthesised outcomes of models of nurse-led survivorship care and contributes a meta-analysis of
patient QoL to survivorship evidence. This review was limited by the risk of bias in many included studies for blinding of
treatment personnel and outcome assessors. Nurse-led care appears beneficial for cancer survivors for some QoL domains.
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Introduction
Advances in cancer care over the past three decades have led to dramatic improvements in survival rates with more than 66%
of Australian cancer patients now surviving more than five years [1]. Multi-modal therapies are associated with numerous
challenges for individuals who live with complex and debilitating side effects, that can interfere with wellbeing and quality of life
(QoL), and disease-related problems [2]. These may include physical, psychological, social and existential needs manifesting as
anxiety, fear of recurrence and uncertainty about the future; social isolation [2]; treatment effects including fatigue, sterility and
loss of sexual function [3]; financial hardship and risk of second cancers and cardiovascular disease [4]. Cancer services in their
current form may no longer have the capacity to provide care for the growth of patients who survive a cancer diagnosis, which in
Australia will result in a projected overall increase of approximately 23-58% in the number of years lived with ill health or
disability [5]. This has led to increased interest in nurse-led models of cancer survivorship care because of the opportunity to
utilise advanced nursing roles and potential advantages over traditional follow-up including improved efficiency, quality of care
and reduced costs [6]. This systematic review aims to determine the effectiveness of nurse-led cancer survivorship care compared
with existing models for survivors who were diagnosed with cancer as adults (age ≥18 years) and who are <2 years post treatment
completion.
Comprehensive care for cancer survivors includes monitoring of: cancer spread; recurrence or second cancers; late effects or
long term psychosocial and physical problems; preventative health; oral and dental health; legal and employment issues; and
financial concerns [7]. The survivorship phase should involve reframing the patient's life which has been disrupted by cancer and
the restoration of personal meaning. This can be guided by the International Classification of Functioning, Disability and Health
(ICF) framework which defines health and health-related well-being domains according to function and restrictions from the
perspective of the body, individual and society [8]. Providing information across the cancer continuum is an important aspect of
care; it promotes coping and self-management and reduces anxiety, and, yet it is a frequently reported unmet need [9]. There is
growing level I and II evidence for integration of healthy lifestyle behaviours as prevention strategies into routine care of patients
with cancer [10-13]. It has been recommended that a written survivorship care plan and treatment summary are provided at the
transition from the specialist to the survivorship program [14,15]. Recent evidence demonstrates that treatment summaries and
care plans provided to patients with a verbal explanation lead to improved self-efficacy in patients more than 2 years from
diagnosis, which is associated with a significantly lower risk of emergency presentation and hospitalisation [16].
A model of care defines the best practice, based on available evidence, for a group of patients with a particular disease
including the care services and activities that should be provided at each stage, their location and health professionals who can
best provide care [17]. Optimal care pathways (OCCP) are tumour-specific guides to best cancer care, recently endorsed
nationally in Australia, which outline the critical steps in the care of a patient diagnosed with a particular cancer [18]. After initial
treatment and recovery the OCCP describes the lead health care professional's role, although the profession is not stipulated. The
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Clinical Oncology Society of Australia (COSA) [15] defined critical components of a wellness model of cancer survivorship care
as: survivor-centred; initiated at diagnosis; integrated across service levels at each stage; coordinated; promotes well-being;
prevents illness; and has accessible and equitable care. In the COSA model care is directed by a needs assessment at diagnosis and
on transition to follow-up. In addition, care is stratified after risk assessment for: disease related comorbidities and recurrence;
treatment sequelae; existing comorbidities; and survivor ability and motivation to self-manage. A number of models of cancer
survivorship care described in the literature are based in hospitals/cancer centres or the community and are led by: cancer
specialists, nurses, family physicians, patients (self-managed) or shared care (two or more clinicians of different specialties) [19].
From a historical perspective, development and implementation of nurse led models of care has been varied and not well
documented. Prior to the introduction of the first nurse-led models of care, advanced practice nursing roles had been developing
for over twenty years (up to the late 1990s) in recognition of the need for nurses to extend their practice [20]. In 2003 Corner [6]
reviewed the first nurse-led care models which were for chronic disease, highlighting that nursing roles at that time largely
functioned within a restricted delegation model rather than a comprehensive advanced practitioner model. Corner reviewed
emerging evidence for nurse-led care in cancer management through identification of a handful of studies. Although there is lack
of clarity about what constitutes a nurse-led model of care [21,22] the following definition by Albarran (2005) is applied in this
review “…in this model, a nurse is responsible for the overall co-ordination, management and continuity of care for a specific
episode of treatment or intervention” [23]. A systematic review of qualitative studies identified key areas of patients' subjective
experience of nurse-led clinics as being: therapeutic relationships enhanced by nurses' interpersonal skills and holistic approach;
effective health communication, language and methods that meets patients' needs and health literacy levels, enabling patients'
independent decisions; respect for specialist nurses' high level of clinical and medical knowledge; and patient-nurse collaboration
empowering patients self-care and management [24]. Our recent work demonstrated that patients who received care from an
experienced Cancer Nurse Coordinator (CNC) experienced a more coordinated patient journey and health professionals viewed
the CNC role as a focal point of contact throughout the patient care trajectory; coordinating all aspects of patient care; providing
patient education and information; and being reliable and accountable [25]. Reported barriers to implementation of nurse-led
models of care include: funding and resource implications; developing service capacity to meet demand; time required to meet
demands of a comparatively onerous audit culture; and lack of visibility and referrals [26].
Studies of nurse-led models of cancer follow-up have been conducted in the following cancer populations: prostate, colorectal,
ovarian, oesophageal, breast, head and neck, mixed and lung [27-33]. Compared with physician-led follow-up, nurse-led followup was found to have comparable safety, adequate detection of cancer recurrence, equivalent health related QoL and patient
satisfaction, reduced medical-specific costs, and similar overall costs [6,27]. Given the increasing interest in nurse-led models of
care and recognition of the importance of cancer survivorship care, this systematic review aims to identify, review and synthesise
publications which evaluated nurse-led models of cancer survivorship care. Specifically, the objective was to determine the
effectiveness of nurse-led care compared with existing models of care for cancer survivors who were diagnosed with cancer as
adults (age ≥18 years) and were <2 years post treatment completion.
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Method
This review followed Cochrane methodology [34] and used Joanna Briggs Institute’s critical appraisal tools [35] to assess risk
of bias in included studies.
Studies
This review included randomised controlled trials (RCTs), non-randomised controlled trials (NRCTs) and controlled beforeafter (CBA) studies. Only studies published in English were included.
Participants
Studies were included if participants were adult cancer patients (aged ≥ 18 years) who were <2 years post cancer treatment
completion.
Interventions
We included studies which evaluated cancer nurse-delivered cancer care, of any frequency or duration, for patients who
completed cancer treatment <2 years previously. The type of care included: monitoring; treatment and/or referral for recurrence;
or assessment and treatment for side effects of treatment or QoL needs including physical, psychosocial, functional, financial,
insurance, occupational, fertility, sexual function, sexuality and spiritual needs. Included studies compared the intervention with
standard follow-up care for the tumour type in any treatment setting, for example delivered by a specialist or general practitioner,
in a primary care or acute hospital setting.
Outcomes
The main outcomes reviewed were patient reported outcomes (e.g. physical and psychosocial symptoms) and other QoL
indicators; resources (human, financial, time, and healthcare facilities) used; and benefits and shortcomings of the model of care
for patients, health professionals and/or the health system. Also considered were: tumour types; key components of the
intervention/nurse's role; patient inclusion criteria; timing of introduction during the treatment continuum including duration and
frequency; and whether a survivorship care plan and/or treatment summary was included. Each model of care was assessed in
terms of the critical components of a wellness model of cancer survivorship care outlined by COSA [15].
Identification of studies
Studies published between 1 January 2007 and 28 July 2017 (previous 10 years) were identified through searches of the
following bibliographic databases: Medline, Pubmed, PsychINFO, Scopus, Psychology & Behavioural Sciences Collection,
Informit (Health Collection), CINAHL and PsychARTICLES. Our pre-study scoping for this study revealed there were few
rigorously evaluated nurse-led cancer services published before our search date range which utilised a comprehensive advanced
5

practitioner model [6] and the definition of what constitutes nurse-led care was inconsistent [23]. Since then, nurse-led care has
evolved [27] and our intention was to include interventions which would best fit with current nursing roles and be applicable to
current health services. Evidence-based practice and clinical practice guideline databases were also searched: JBI Connect,
Worldviews on Evidence-based Nursing, Database of Abstracts of Reviews of Effects and Cochrane Library of Systematic
Reviews. The following were hand searched: Nursing Research Journal; National Institute for Health and Care Excellence;
National Guideline Clearinghouse and NHMRC Clinical Practice Guidelines Portal Australia. Keywords were selected from
relevant publications and additional keywords were found by searching the Medical Subject Headings database
(http://www.ncbi.nlm.nih.gov/). The search strategy was tested and the final strategy and keywords were decided by the research
team (Table 1). Both spelling variations of tumour (tumor) were included in searches of all sources, apart from JBI Connect, in
which the 'tumor' variant was inadvertently omitted; this is an Australian resource, a language in which the ‘tumour’ spelling is
used, which provided a small proportion (6%) of our total search results; later testing revealed that adding the ‘tumor’ variant
would only have resulted in an approximate and negligible 2% change to results. Depending on database functionality, truncation
and wildcard searching were allowed and limits to English language and human studies were applied.
Data collection
A total of 8824 results were obtained from bibliographic databases. Following removal of a large proportion of duplicates 5077
articles were included. Of these, 4355 citations were excluded based on the title and 722 abstracts were screened. One hundred
and seventy-six full-text articles were retrieved and further assessed for eligibility. Of these 21 articles met the inclusion criteria.
A total of 155 articles were excluded for reasons shown in Figure 1 which describes the data evaluation phase using the Preferred
Reporting Items for Systematic Reviews and Meta-Analyses [36]. Three papers, which otherwise met inclusion criteria, were
excluded because two were earlier precursor trials or feasibility tests of included studies and for one paper we were unable to
assess methodological quality of study processes due to lack of clarity in the final published paper. Abstracts or dissertations were
excluded. One reviewer independently selected relevant titles and abstracts (MB), and all problematic decisions were discussed
with a second reviewer (LM). Both reviewers confirmed the final list of included papers met the inclusion criteria. The reference
lists of included studies were searched for suitable articles and relevant titles underwent the same review process described.
Outcome measures data described above, along with publication information, study characteristics, participant information, key
components of the nurse-led intervention, and main findings, were extracted from each included paper by one reviewer (MB) and
were checked by a second reviewer (LM). Risk of bias of included studies were independently assessed by two reviewers (LM,
MB) by use of Joanna Briggs Institute’s critical appraisal tools for RCTs and Quasi-Experimental Studies [35] and discrepancies
were resolved by discussion.
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Data synthesis
The narrative synthesis presented findings where three or more included studies measured conceptually similar outcomes and
included: quality of life and psychological measures; symptoms; patient satisfaction; and economic measures. RevMan (Review
Manager version 5.3.5) [37] was used to conduct meta-analyses where three or more studies had used the same instrument and
reported a group mean, standard deviation and sample size. Seven studies used the EORTC QLQ-C30 instrument (four reported
all sub-scales) and three used the CES-D; both instruments report continuous data. Because the timing of intervention initiation
relative to cancer treatment and intervention duration varied across studies, all outcomes were categorized based on time since the
start of the intervention which was treated as a sub-group in the analysis: during the intervention up to 3 months, 4-6 months and
7-23 months, and after completion of the intervention. Studies which reported measurement times in terms of time since baseline
were realigned relative to intervention start and if baseline measures occurred during a long recruitment period, the median time
between baseline and intervention start was used to re-align the data. Where studies used repeated measurements within a defined
time period, the data was averaged within groups. For each study reporting findings for the specified domain within the time
period, the mean difference between intervention and control groups and 95% CI was calculated. A random effects inverse
variance model was used. Pooled results by time period and individual results are presented using forest plots. Heterogeneity was
determined using the Chi2 test (p<0.10) [38] and the I2 statistic (0-30% low, 30-50% moderate, >50% substantial) [38,39]. For
reasons of brevity, only meta-analyses with a significant overall effect test at any time period are presented in this paper. The
corresponding author can be contacted regarding the remaining non-significant meta-analyses.

Results
Description of included studies
Twenty one [30,40-59] publications described 15 interventions of nurse-led models of care for cancer survivorship. Extracted
data are presented in Supplement 2; six publications [44,50,51,53,55,56] were secondary analyses of included trials (e.g.
economic, rural or a long term time point) and their findings are considered together with the original publication in this review
and are reported in the same table row. Twelve studies were RCTs, two were CBA studies and one was a randomised case-control
study. The interventions were compared to physician-led follow-up [41,46,48,57,58], conventional nursing care [47,54], usual
multi-disciplinary hospital care [43], no intervention [42] or usual care (provider not described) [30,45,59]. Some comparison
groups consisted of “attention control”, with referral to physicians if needed [40,49], or attention control in addition to multidisciplinary care [31].
Participant characteristics
Total sample sizes of studies ranged from N=70 [40] to N=756 [59]; most studies had two groups of equivalent size, apart from
one study with 3 groups (2 experimental, 1 control) [54] and one 2x2 factorial design RCT [43]. The average age of participants,
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reported for the total sample or each study group separately, ranged from 46.1 to 70.2 years. Details of anticancer treatment varied
in each study and are shown in Supplement 2. Eligible participants in the majority of studies (12 of 15) had received surgical
treatment with or without chemotherapy or radiation therapy. No studies reported patients had received immunotherapy.
Description of interventions
Models of care were tumour-specific and for adult survivors with the following cancers: breast [42,43,45,52,54], gynecological
[40,47,49], head and neck [41,57], colorectal [30,59], oesophageal or gastric cardia [48,58] and prostate [46]. Two interventions
commenced during surgical inpatient treatment and provided preoperative, postoperative and discharge care for gynaecological
cancer patients with follow-up at home [40] or discharge care for oesophageal and gastric cardia cancer patients with telephone
follow-up [48]. Of the remaining interventions, the majority commenced after treatment completion [30,41-43,46,47,52,57-59],
while in three studies care began during outpatient treatment [45,49,54]. Care settings and/or modalities included: an outpatient
setting [42,57]; both outpatient and telephone follow-up [30,41,52]; telephone follow-up [45,46,48,54,59] with optional outpatient
clinic visits [43]; both telephone follow-up and home visits [47,49] or only home visits [58]. Most interventions continued for 6
months [46-49,52,54,59], or continued for either 3 months [30,40], 12 months [41,57,58], 18 months [43], up to 5 years [45] or
involved only one consultation after treatment [42]. Almost all followed a planned follow-up schedule of predominantly evenly
spaced visits [41,43,46,47,52,54,57]. However, some initially required frequent visits which reduced in frequency over time
[30,48,49,59]. The interventions frequently involved six visits [41,46,54,57,58], or less [30,40,42,43,59] however, one involved
eight visits [52] and three involved more than 12 visits [47-49]. One had an open access model and the average number of patient
contacts was not reported [45].
The qualifications and experience of nurses were incompletely described across studies. Nurses were generally described as
either oncology nurses or an advanced practice nurses, or sometimes both (Supplement 2). In a number of studies nurses were
trained for delivery of the intervention [30,41,43,52,57-59]. In the majority of interventions, nurses provided the following three
elements of care: patient assessment, general management of a problem and patient education or advice
[30,40,41,43,45,46,48,49,52,57,59] while others provided one or two elements [42,54,58]. A few interventions included discharge
planning [40,43,48] with several designed to promote well-being and prevent illness [30,42,45,47-49,52,54], or well-being alone
[57,59]. Nurses made referrals to other health care providers [41,46,48,49,58] or ordered and/or reviewed tests [43,45] in some
models of care. A patient manual or resource was used in five survivorship models of care [30,40,42,45,52].
Many models of care included some of the recommended features of survivorship care such as individualised care
[30,41,43,45,46,48,49,52,57-59] and patient self-management [40,43,45,49,52,54,59]. Inclusion of the following elements of
survivorship care was less frequently observed: integration of care across service levels [40,45,46,58,59]; coordinated care
[46,48,49,59]; survivorship care plans and treatment summaries [30,42] and risk stratification [45,46,49]. Some issues regarding
whether care was accessible or equitable were identified with almost all studies, likely related to the constraints of conducting a
randomised controlled trial. Examples included the exclusion of patients with: higher grade, non-primary, or metastatic cancers;
8

co-morbidities/disabilities; cognitive impairments; psychiatric illnesses/mental health conditions; illiteracy; or limited travel or
phone access.
Description of outcomes
Aside from one study, all included a QoL measure as an outcome [30,41-43,45,47-49,54,57-59], or a cancer survivorshipspecific QoL measure [40,52] for example, Quality of Life Scale/Cancer Survivors (QOL-CS). Most studies measured symptom
outcomes, either tumour-specific [30,41,45-48,57,58] or more common cancer-related symptoms [42,49]. Some studies assessed
patient anxiety [30,43,45,57], depression [30,42,45,49,57], distress [30,46,49,54,59], coping [54,57] or perceived stress [54]. In
addition, three studies [43,49,54] measured more specific psychological measures e.g. affect regulation. Other survivorship
outcomes included unmet needs or problems [30,42,59], cancer care coordination [59] and health literacy or perceived
information provision [42,48]. A few studies measured family function, social constraint or support outcomes, or psycho-social
adjustment [41,47,54,57] and three studies measured patient satisfaction [30,42,46].
Risk of bias
The assessment of risk of bias in each study is shown in Figure 2. All studies were rated as having a high or unclear risk of bias
for blinding of treatment personnel which is a probable consequence of the interventions being delivered by an alternative
provider. Whether outcome assessors were blinded was not addressed in almost all studies, resulting in a predominantly unclear
risk for this item. As patient reported outcomes were the primary outcomes in the included studies, whether outcomes were
measured reliably was not applicable to most studies and there was low risk of bias in relation to whether outcomes were
measured in the same way for all groups.
Effects of interventions
Quality of life
The duration and timing of interventions and outcome measurements varied between studies with many studies measuring
outcomes at multiple times including at baseline, during the intervention period through to completion and post-completion
follow-up. This review therefore considered findings in terms of four time periods: during the intervention up to 3 months
[40,43,48,49,52,55,58,59], 4-6 months [41,45-49,52,55,58,59] and 7-23 months [43,45,55], and after completion of the
intervention [30,41,42,54,55,58]. Three studies reported group effects with other factors included in the analysis such as time in 2
way ANOVAs [54] or mixed effect regressions [49], or age in nested models [45].
In studies which measured QoL or specific domains, there were no significant differences between groups when measured
during the intervention from 0 to 3 months and 4-6 months in: physical [41,48,58,59], emotional [41,43,48,58,59], role
[43,48,58,59], social [41,48,58,59] and overall QoL [41,43,48,58,59]. Two studies measured QoL during the intervention (7-23
months), one demonstrated a beneficial intervention effect on physical and emotional function [55], while the other demonstrated
9

no effect on emotional function and did not report physical QoL [43], and neither demonstrated an effect of the intervention on
role or social function [43,55]. Three studies demonstrated a beneficial intervention effect when measured after its completion for
overall QoL [41,47,55], physical [41], emotional [47,55], role [41,55], or social QoL domains [41,47]. Adverse intervention
effects were less frequently demonstrated; one study found an effect in the QoL role domain when measured after the intervention
[47]. Three studies investigated QoL outcomes in terms of change over time and found no significant differences between the
experimental and control groups [45,49,54], but found significant effects of time [49,54] or a significant predictor of patient age
[45]. Of the two studies which measured cancer survivorship-specific QoL during the intervention [40,52], both demonstrated a
significant benefit of the intervention for overall QoL, and psychological and social domains. One study demonstrated beneficial
effects of the intervention for physical and spiritual QoL domains [40] whereas the other showed no intervention effect in these
domains [52].
Most studies found no difference between groups for psychological distress levels at any time period [30,41,46,59] or group
differences with time included as a factor [54]. In studies which measured anxiety, no group differences were demonstrated at any
time period [30,43,45,48]. Findings for depression were mixed. One intervention showed benefit during (approximately 10
months) and shortly after completion of the intervention but this difference was not sustained at longer term follow-up
approximately 10 months later [55,57]. Another study found no group differences for depression following the intervention (3
months) or at long term follow-up (6 months) [42]. One study demonstrated significantly higher depressive symptoms in patients
who received the nurse-led intervention during the intervention (6 months) [49].
Symptoms and patient satisfaction
The following outlines specific QoL domain outcomes reported in three or more studies. Of studies which reported pain
domain outcomes, no effect was found during the intervention when measured up to 3 months [48,58] or 4 to 6 months [41,48,58]
however one study demonstrated that intervention participants experienced less pain at 7 to 23 months [55]. After completion of
the intervention findings were mixed; two studies demonstrated a benefit to the intervention group [41,55] and three studies found
no effect [30,58]. There were no significant differences in pain symptoms between groups when analysed in nested models with
age included [45]. No effect of the intervention was demonstrated for any sexuality domains when measured during the
intervention at up to 3 months [59], 4 to 6 months [41] or 7 to 23 months [55]. After the intervention, most studies found no effect
of the intervention on sexuality [30,41,45,46,55] however, one demonstrated a benefit [47]. Several studies investigated body
image however, no significant differences between groups at any time were reported [30,45,48]. In studies which measured unmet
needs, including survivorship-specific measures, one study found reduced health worry in the intervention group post intervention
[42] and two found no significant group difference during or after completion of the intervention [30,59]. One study found a
significant benefit for the intervention in relation to patient satisfaction [30], another study found no difference [53] and another
study showed increased satisfaction for spouses only [58] .
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Economic analyses
Three studies undertook economic evaluations or assessed economic implications. Two studies which substituted nurse-led
care for usual care found cost reductions. Polinder et al [53] found costs of nurse-led visits were significantly less than standard
visits (€234 versus €503; p<0.001). The average cost of nurse-led follow-up was lower than standard care (€2592 versus €3798;
p=0.11) even though more patients in the nurse-led group attended all five protocol visits (82% vs 60%; p=0.002) [53]. Kimman
et al [44] found that nurse-led telephone follow-up with group education was most cost-effective for mean annual costs (€3 971,
95%CI, 2975–5186) and had the second highest mean quality-adjusted life years (0.772, 95%CI, 0.745–0.797; highest 0.776,
95%CI, 0.753-0.799) of the strategies tested. McCorkle et al found that significantly fewer patients who received the nursing
intervention had one or more primary care visits (mean=2.75 (S.D.=2.03) vs 3.59 (S.D.=4.66)) during 6 months post-surgery
however, the related costs were not reported [50].
Quality of life meta-analysis
Four significant mean differences between groups were found by meta-analysis, all were in domains of the EORTC QLQ-C30.
During the intervention (4-6 months) in the intervention group, cognitive functioning was significantly higher by 4.04 units on
average (MD=4.04, 95%CI [0.59, 7.50], 463 participants, p=0.02; I2=24%; Figure 3) and social functioning was significantly
higher by 3.06 units on average (MD=3.06, 95%CI [0.14, 5.97], 463 participants, p=0.04; I2=0%; Figure 4). Appetite loss during
the intervention (4-6 months) was significantly lower in the control group by 4.43 units on average (MD=4.43, 95%CI [0.08,
8.78], 354 participants, p=0.05; I2=0%; Figure 5). After the intervention, symptoms of fatigue were significantly reduced in the
intervention group by 4.45 units on average (MD=-4.45, 95%CI [-7.93,-0.97], 647 participants, p=0.01; I2=15%; Figure 6).

Discussion
This systematic review of literature published over a ten year period found 15 RCTs and CBA studies of nurse-led models of
cancer survivorship care for patients with breast, gynecological, head and neck, colorectal, oesophageal or gastric cardia or
prostate cancer, and who were within two years of treatment completion. The majority of nurse-led survivorship interventions
commenced after treatment completion and continued for 6 months with a planned schedule of 6 or less evenly spaced visits. Care
settings and intervention modalities varied and included outpatient, telephone, home or a combination of settings. Nurses were
generally described as either oncology nurses or advanced practice nurses, or sometimes both, although this was incompletely
described across studies. In most models of care, the nurse’s role included at least two of the following elements: patient
assessment, general management of a problem, and patient education or advice. Some recommended features of survivorship care
[15] were delivered such as individualised care, patient self-management, illness prevention and well-being promotion however,
other recommended elements were less frequently observed.
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Almost all studies assessed QoL and most studies measured tumour-specific or common cancer-related symptom outcomes.
Several also included psychological measures and some evaluated unmet needs, care coordination, health information and patient
satisfaction. Generally, within studies, there were few significant differences between the control group and the nurse-led care
group for most measures. Some studies demonstrated a benefit of nurse-led survivorship care post intervention completion on:
emotional [47,55], physical [41], role [41,55], social [41,47] and global QoL [41,47,55]; pain [41,55]; sexuality [47]; and
depression [55]. During the intervention, benefits of nurse-led care were found for emotional and physical QoL [55], and
depression [55] and pain [55]. These findings were predominantly from two studies [41,55] which were notable for being the two
head and neck tumour models of care, both of 12 months duration with 6 visits.
Meta-analysis of the EORTC-C30 scale scores synthesised the results from seven studies and found higher cognitive and social
functioning in patients who were receiving the nurse-led survivorship intervention (4-6 months). Post intervention completion,
patients who had received the nurse-led survivorship care intervention had significantly reduced fatigue symptoms. Although a
number of previous reviews have focused on nurse-led models of survivorship care [27,60,61], this is one of the first known metaanalyses of patient QoL outcomes after nurse-led survivorship care. The finding that nurse-led care provides a benefit to cancer
survivors in terms of cognitive and social QoL is an important contribution which suggests cancer nurses can assist survivors
adjust to life after treatment and nurse-led care results in reduced fatigue symptoms for cancer survivors in the longer term.
One deleterious effect of nurse-led interventions found by meta-analysis was appetite loss (4-6 months) that was significantly
lower in the control group. Half of the weighting for this sub-group analysis was attributed to head and neck, esophageal and
gastric cardia models of care. Side effects from these tumour groups and their treatment impact on appetite [62,63] and it is
possible the interventions improved patients' abilities to identify and report symptoms of appetite loss as a consequence of nurses
focusing care on these symptoms. Alternatively, this finding could indicate that nurse-led care during treatment does have a
deleterious effect on appetite loss possibly through inappropriate or insufficient management of symptoms impacting on appetite.
This would highlight a need for further nursing education, and/or referral to specialist health professionals such as dietitians or
nutritionists to more appropriately support patients' symptoms of appetite loss. Post intervention completion, appetite loss scores
were not significantly different in the meta- analysis; scores were evenly weighted from studies with participants with head and
neck and colorectal tumours. Future research should explore these effects on appetite loss or malnutrition in patients who
experience nurse-led models of survivorship care; qualitative nursing research may provide areas for future investigation of this
issue. Two individual studies did report significantly worse scores in the intervention group for depression during the intervention
(4-6 months) [49] and role functioning QoL post intervention [47]. Both evaluated nurse-led survivorship care for gynaecological
cancers and one study had a number of concerns related to unclear or high risk of bias [49].
Apart from the meta-analysis and other significant findings discussed, there were no significant differences between the control
and nurse-led care group for most measures. Although this suggests outcomes from nurse-led models of cancer survivorship care
are not inferior to standard care, this conclusion cannot be drawn as the randomized controlled trials were not designed to
demonstrate non-inferiority. Future prospective studies would need to determine the non-inferiority margin for death, recurrence,
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symptoms or QoL outcomes, for which this meta-analysis may provide some guidance, and would require a larger sample size due
to the smaller margin and higher study power required [64].
As well as providing a benefit to patients, interventions should be sustainable and economically viable through a measurable
reduction in costs, reduced workload and demand on current services. Although few studies included an economic analysis, the
general hypothesis that nurse-led care substituted for usual care can be cost effective, neutral, or reduces health service utilisation
appeared to be supported [44,53]. Some studies required multi-disciplinary team input for development of evidence based
algorithms [41,46,59] or patient resources [30,45,49,52,55] and ongoing input may be required for their maintenance. Many
interventions were supplementary to usual care and therefore would have financial and resource implications [30,41,47,48,55,59],
whereas others may be practically difficult to implement routinely, in particular the multi-faceted home-based health promotion
program by Li et al. [47].
Potential deficits in the construct of the nurse-led models of care were observed by this systematic review. Some interventions
provided support for patients to meet financial needs [41,42,45,48,52,55], occupation and/or insurance needs [30,42,45,52,55].
These needs have been identified as important areas of survivorship care [65,66] and in cancer care, the impact of financial
toxicity for patients has been recently acknowledged [67]. Interestingly, despite consistent recommendations and recent evidence
supporting their use [14,16], only two included interventions provided survivorship care plans and/or treatment summaries to
patients [30,42].
Limitations
We acknowledge this review was limited by the focus on English articles and the omission of unpublished data. Therefore
findings may reflect a publication bias. However, many studies appeared to have multi-disciplinary stakeholder investment which
could potentially have improved the likelihood of publication regardless of findings. The meta-analysis strengthened findings of
this review however we observed that three of the four significant findings included data from the same four publications due to
the limited number of papers which used the EORTC-QLQ instrument in the time period analysed; this may have biased results
however the studies used diverse tumour groups (n=2 gastric; n=1 head and neck, and n=1 breast). An exploratory literature
search identified that a number of randomised controlled trials of nurse-led models of cancer survivorship care are currently
underway [68-71]. As more data is published this meta-analysis should be repeated to verify the findings. Our literature search
omitted some broad models of care terms, such as patient engagement, patient empowerment and patient activation, which should
be considered in future reviews. However we propose the scope of our search terms enabled identification of the majority of
relevant studies that used such methods.

Conclusion
This systematic review identified 15 RCT or CBA evaluations of nurse-led cancer survivorship models of care and presented a
meta-analysis. The tumour-specific models of care for a variety of tumours were generally introduced after treatment completion
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with a planned schedule delivered over 6 months and provided patient assessment, clinical management of a problem, education
or advice, individualised care, and supported self-management. Meta-analysis found a significant benefit to survivors who
received nurse-led care for cognitive and social QoL, and fatigue; however control patients reported significantly lower appetite
loss symptoms. This comprehensive systematic review provides a synthesis of nurse-led models of survivorship care, describes
the patient outcomes compared with usual follow-up and contributes a meta-analysis of patient QoL outcomes to survivorship
research. Role delegation to nurse-led survivorship care appears to be reliable and feasible, and shows good performance
compared to standard approaches. A multi-disciplinary setting which provides comprehensive survivorship care, through access to
other specialist non-physician providers, may be a necessary component of nurse-led models of care. As more RCTs are
published, the meta-analysis of QoL findings should be repeated to confirm these findings and future studies of nurse-led models
of survivorship care should consider appropriate study designs and measures to ensure applicability and transferability of findings.
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Figure titles
Figure 1 Search results and screening for nurse-led cancer survivorship models of care reported using the PRISMA.

Figure 2 Risk of bias summary: review authors' judgements about each risk of bias item for each study included in the metaanalysis of PROMs. NRCT - Item only applicable to non-randomised controlled trial.

Figure 3 Forest plot of comparison of cognitive function quality of life, measured by European Organisation for Research and
Treatment of Cancer Quality of Life Questionnaire (EORTC-QLQ), in cancer survivor intervention and control participants in
studies of nurse- cancer survivorship care.
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Figure 4 Forest plot of comparison of social function quality of life, measured by European Organisation for Research and
Treatment of Cancer Quality of Life Questionnaire (EORTC-QLQ), in cancer survivor intervention and control participants in
studies of nurse- cancer survivorship care.

Figure 5 Forest plot of comparison of appetite loss symptoms, measured by European Organisation for Research and Treatment
of Cancer Quality of Life Questionnaire (EORTC-QLQ), in cancer survivor intervention and control participants in studies of
nurse- cancer survivorship care.

Figure 6 Forest plot of comparison of fatigue symptoms, measured by European Organisation for Research and Treatment of
Cancer Quality of Life Questionnaire (EORTC-QLQ), in cancer survivor intervention and control participants in studies of nursecancer survivorship care.
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Search
Terms

Cancer
cancer
carcinoma
malignancy
neoplasm
oncology
tumour

2.

Survivorship
after cancer
after treatment/s
cancer survivor/s
follow-up
late effects
life after cancer
life after cancer care
living with cancer
long term effects
long-term survivor/s
post treatment/s
survivor/s
survivorship
survivorship care

3.

Nursing

Models of care
care
continuity of patient care
follow up studies
health care
healthcare
health care delivery
healthcare delivery
health service
health status
managed care
model of care
oncology model
optimal care pathway
optimal pathway
outcome
patient care planning
patient education
quality of life
rehabilitation
self care
self-management
survivorship care plan

Clinical nurse specialist
Macmillan nurse
Nurse
nurse practitioner
nurse specialist
nurse’s practice patterns
nurse’s role
nurse-led
nurse-led service
nursing administration research
nursing intervention
nursing model
nursing staff
oncology nursing
specialist nurse
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Supplement 1 Data extracted from included publications which described nurse-led models of cancer survivorship care
Author,
year,
location
Need to Study
add
design
citations
when
final

Cancer type,
treatment,
sample size
(consent
rate (CR) %)

Key components of
nurse's role/
Potential
intervention
benefits of
timeframe and
the MoC
description

Potential
deficits of
the MoC

Outcome
measures

Results

Aktas & Randomized Ovarian,
Terzioglu, case control endometrial
2015 [40], study
and cervical
Turkey
(stage 1-3);
surg., +/chemo., +/RT; n(C)=35,
n(I)=35
(CR=NP)

No details of nurse's
qualification or
experience provided.
From surgical
admission to 12
weeks discharge
monitoring.
Pre/postoperative
care and discharge
teaching (DT) in line
with the Nursing
Care Plans. Home
care visits of 60-90
minutes in 1st and
12th week postdischarge (wound
care, drug and pain
management,
resolving of physical,
psychological and
social problems,
nutrition, medication
management).

Home
service
prevented
and
addressed
patient’s
problems,
including
sexuality.

Support
does not
appear to be
provided for
financial,
occupational
or insurance
related
needs.

Home Visit
Monitoring
Form (49
items);
Quality of
Life
Scale/Cance
r Survivors
(QOL-CS)

De Leeuw Controlled
et. al.,
before and
2013 [41], after study
Netherlan
ds

Oncology RNs with
mean 11 years’
experience (6-20) in
head and neck
oncology. Trained for
intervention (8 hours)
with 3-monthly
clinical supervision
meetings. During first

Improved
QoL
outcomes
for patients.
Potentially
modifiable
for other
cancer
populations.

At 12
months,
there was a
negative
impact of
intervention
on healthcare
orientation,

EORTC
• The intervention group demonstrated significantly poorer
Quality of
adjustment at baseline in the following sub-domains of the
Life
PAIS-SR: health-care orientation, social environment and
Questionnair total adjustment (p<0.05). At 6 months, there were no
e (QLQdifferences between the groups. At 12 months, the
C30);
intervention group had poorer adjustment in health-care
EORTC
orientation (p<0.02).
Head & Neck • Change in baseline PAIS-SR was compared between
Module
groups and for the domain of social environment, the

Head and
neck (stage
I-IV, primary
diagnosis);
+/- surg., +/chemo. or +/RT; n(C)=80,
n(I)=80
(CR=94.1)

Level
of evidence

• Intervention group had lower “loss of sexual attractiveness” II or IV
and “deficient/defective feeling” about body image (p<0.05).
• Intervention group had higher QoL, and higher physical,
social, psychological and spiritual well-being (p<0.05).
• Physical problems in the intervention group were observed
to be half of control patients: abdominal distension,
immobilization, insomnia and fatigue (p<0.05).
• Fatigue was the most important problem affecting physical
health in both groups.
• Family stress and sexuality were the most important
problems affecting the social well-being in both groups.
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Author,
year,
location
Need to Study
add
design
citations
when
final

Cancer type,
treatment,
sample size
(consent
rate (CR) %)

Key components of
nurse's role/
Potential
intervention
benefits of
timeframe and
the MoC
description
year post-treatment.
Six 30 minute faceto-face follow-up
consultations with
nurse, following a
standardised
protocol, in parallel
and preceding
medical routine visits.
Included a needs
assessment based
on the bio-psychosocial model.

Hershma Singlen et. al., blinded

Breast (stage Nurse practitioners.
0–III); surg., After adjuvant
+/- chemo. or therapy completed,

Most
important
survivorship
QoL needs
addressed.
Followed a
bio-psychosocial
model.

Potential
deficits of
the MoC

possibly due
to increased
healthcare
awareness.
Support
does not
appear to be
provided for
occupation
or insurance
related
needs.
Supplement
ary to usual
care, and
therefore
requires
greater
resources
for
implementati
on.

Outcome
measures

Results

Level
of evidence

(QLQintervention group had significant worse scores at baseline
H&N35);
(p<0.05) but a 7.8-point (95 % CI=2.3, 13.2, p<0.01) and
Psychosocial 6.7-point (95 % CI=1.3, 12.2, p<0.02) larger improvement
Adjustment
than the control group at 6 and 12 months, respectively.
to Illness
• Clinically relevant changes in PAIS-SR (≥ 1 S.D.): equal
Scale—Self
numbers of patients in both groups had improved by at least
Report
1 standard deviation at 6 and 12 months; at 6 months, more
(PAIS-SR);
patients had deteriorated in the intervention group than in
the comparison group, the largest difference was in the
social environment domain, with twice as many deteriorated
patients in the intervention group as in the comparison
group (27 vs. 13 patients, respectively); at 12 months, the
number of deteriorated patients was approximately equal
between groups.
• For EORTC scales, baseline mean scores were significantly
worse (p<0.05) for the intervention group. At 6 and 12
months, the mean scores were not significantly different
between groups and changes from baseline at each time
point were significantly larger for the intervention group for
global health status/QOL, 3 of 5 functional scales, 6 of the 9
generic symptom scales, and 9 of 18 specific head and
neck scales.
• Clinically relevant changes in EORTC scales (≥ 10 points)
for at least 10 more patients in the intervention group
compared with the control group was observed for: global
health status/QOL, 3 of the 5 functional scales, 3 of the 9
generic symptom scales, and for 11 of the 18 specific head
and neck scales. The largest difference between groups,
favouring the intervention group, was for fatigue at 6
months and for pain and social eating at 12 months.

Important
Intervention Physical and • Control group had a higher score on the physical health
survivorship used more functional
awareness scale (more health awareness) of the IOC
QoL needs health care
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Author,
year,
location
Need to Study
add
design
citations
when
final
2013 [42], randomized
USA
trial

Cancer type,
treatment,
sample size
(consent
rate (CR) %)

Key components of
nurse's role/
Potential
intervention
benefits of
timeframe and
the MoC
description

+/-RT, +/HT; n(C)=60,
n(I)=66
(CR=44.5)

patients were given
NCI publication
Facing Forward and
met with nurse and a
nutritionist for 1 hour
to receive
personalised TS,
surveillance
recommendations,
discuss risk of late
effects and toxicities,
and screening and
lifestyle
recommendations.
Visit content followed
treatment summaries
guidelines by
American Society of
Clinical Oncology.

addressed.
Personalise
d TS
provided.

Potential
deficits of
the MoC

resources
and was
associated
with
increased
costs.
Publication
may require
revision in
the future to
address any
changes in
evidence.

Outcome
measures

well-being
sub-scales of
the
Functional
Assessment
of Cancer
Therapy
(FACT);
Center for
Epidemiologi
c Studies
Depression
(CES-D)
scale; 3-item
health
literacy
assessment;
Memorial
Symptoms
Assessment
Scale
(MMAS);
Impact of
Cancer (IOC)
scale;
Functional
Assessment
of Chronic
Illness
Therapy
Treatment
Satisfaction
PatientSatisfaction

Results

(p=0.04) at baseline but groups were not significantly
different at 3 and 6 months.
• At 3 months, the intervention group scored significantly
lower (less worry) on the health worry (p=0.01) and health
worry subscale (p=0.02) of the ASC however, the difference
did not persist at 6 months. The health worry subscale
increased (more worry) signiﬁcantly in the control group and
decreased signiﬁcantly in the intervention group (p = 0.05).
• At 3 months, the intervention group scored significantly
lower on the existential negative outlook scale on the IOC
compared with the control group (p=0.04) however, the
change from baseline was not significant between groups.
• Patients with higher physical awareness had higher health
worry (p = 0.008).
• A multivariable exploratory linear regression analysis
controlling for age, stage, ethnicity, education, marital
status, employment, income, and health literacy confirmed
the relationship between the intervention and less health
worry (p=0.04).
• No difference in total scores or subscale scores between
the control and intervention groups on the FACIT-TS-PS,
FACT (physical/ functional), or CES-D scores.

Level
of evidence

Author,
year,
location
Need to Study
add
design
citations
when
final

Cancer type,
treatment,
sample size
(consent
rate (CR) %)

Key components of
nurse's role/
Potential
intervention
benefits of
timeframe and
the MoC
description

Potential
deficits of
the MoC

Outcome
measures

Results

Level
of evidence

(FACIT-TSPS);
Assessment
of Survivor
Concerns
(ASC)
Jefford et. Multisite,
al., 2016 multistate,
[30],
RCT
Australia

Colon or
rectal (stage
I-III); surg.,
+/- chemo.,
+/-RT;
n(C)=110,
n(I)=107
(CR=57.6)

No details of nurse's
qualification or
experience provided.
Trained in all aspects
of the protocol. Care
started up to 6
months after the end
of treatment.
SurvivorCare
intervention
consisted of: an
information package;
personalised SCP;
an individualised 1
hour nurse-led faceto-face end of
treatment session to
respond to
immediate and
pertinent concerns,
discuss SCP,
common issues and
healthy lifestyle; and
telephone follow-up
at 1, 3, and 7 weeks
after initial session.

Patients
more
satisfied
with posttreatment
care
provided.
Personalise
d SCP
provided.
Majority of
important
survivorship
QoL needs
addressed.

Six month
timeframe
for
intervention
delivery;
patient
variation not
addressed
by analysis.
Patient
resources
provided
may require
revision in
the future to
address any
changes in
evidence.
Support
does not
appear to be
provided for
financial or
insurance
related
needs.
Supplement

Brief
Symptom
Inventory 18
(BSI-18);
The Cancer
Survivors’
Unmet
Needs
measure
(CaSUN);
EORTC
Quality of
Life
Questionnair
e (QLQC30);
EORTC
Colorectal
Cancer
module
(EORTC
QLQ CR-29);
perceptions
of posttreatment
care.

II
• The primary outcome, psychological distress at 2 months
post baseline, was not significantly different between
groups.
• There were no significant differences between groups for:
psychological distress (6 months); cancer survivor unmet
needs sub-scales (2 and 6 months); and symptoms and
functioning QoL sub-scales (2 and 6 months).
• Intervention group participants were more satisfied with
care provided than usual care participants, with statistical
differences between groups on the majority of items.
Median scores for most items were the same, but
interquartile ranges indicated that more intervention
participants “agreed” or “strongly agreed” with item content
than did usual-care participants.
• Overall, levels of distress were low and QOL was generally
quite good.

Author,
year,
location
Need to Study
add
design
citations
when
final

Cancer type,
treatment,
sample size
(consent
rate (CR) %)

Key components of
nurse's role/
Potential
intervention
benefits of
timeframe and
the MoC
description

Potential
deficits of
the MoC

Level
of evidence

Outcome
measures

Results

EORTC
Quality of
Life
Questionnair
e (QLQC30); anxiety
(State-Trait
Anxiety
Inventory
(STAI));
perceived
feelings of
control
(Mastery
Scale);
patient
records and
cost diaries
for number of
visits to
hospital,
telephone
contacts with
medical

II
• Nurse-led group patients had on average 2.4 telephone
contacts with the BCN and 3.4 visits to the hospital, of
which one hospital visit conformed to protocol and 2.4 were
additional visits. Hospital group patients had on average 5.9
visits to the hospital, of which four visits conformed to
protocol and 1.9 were additional visits. The mean number of
general practitioner visits did not differ between groups.
• Mean health related QoL scores were not significantly
different between nurse-led and hospital follow-up groups at
12 months. The 95% conﬁdence interval for the estimated
difference (positive difference favours nurse-led follow-up)
between mean HRQoL scores at 12 months after treatment
was -1.93 – 4.64.
• HRQoL signiﬁcantly improved over time (p=0.01), but
without signiﬁcant differences in slope of improvement
between both follow-up groups (p = 0.41).
• There was no signiﬁcant difference in health related QoL
between follow-up with or without EGP. The 95%
conﬁdence interval for the estimated difference (positive
difference favours EGP) between mean health related QoL
scores at 12 months was -3.59–3.00. There was no
signiﬁcant difference in slope of improvement between
follow-up groups.

ary to usual
care, and
therefore
requires
greater
resources
for
implementati
on.
Kimman
et. al.,
2011 [43];
Kimman
et. al.,
2011 [44],
Netherlan
ds

Multicentre
pragmatic
RCT with a 2
x 2 factorial
design
(nurse-led vs
hospital
follow-up and
educational
group
program or
not)

Breast (stage
I-III); surg.,
+/- chemo.,
+/-RT, +/HT;
n(C)=149,
n(I)=150 and
n(EGP)
=149,
n(NoEGP)
=150
(CR=36.3)

Breast care nurse
specifically trained
for the study. Started
within 6 weeks after
end of final treatment
(excluding HT). One
semi-structured
telephone interview
which included
screening for
physical and
psychological
symptoms, treatment
side-effects and
hormonal therapy
compliance.
Additional
appointment with
BCN at hospital if
required.
An additional study
component, an
educational group
program (EGP)

High patient
satisfaction.
Cost
effective and
potential
overall cost
difference
compared
with
standard
care.

Support
does not
appear to be
provided for
financial,
occupational
or insurance
related
needs.
Group
program
may be
inconvenient
for patients
to attend.

Author,
year,
location
Need to Study
add
design
citations
when
final

Cancer type,
treatment,
sample size
(consent
rate (CR) %)

Key components of
nurse's role/
Potential
intervention
benefits of
timeframe and
the MoC
description

Potential
deficits of
the MoC

presented by the
BCN and a
psychologist
consisted of 2
interactive 2.5 hour
group sessions for
patients +/- their
partner within 3
months posttreatment.

Kirshbau RCT
m et. al.,
2017 [45],
UK

Breast (stage
1 or 2, lowrisk); surg.,
+/- RT;
n(C)=56,
n(I)=56
(CR=NP)

Breast care nurse
role extended to
advanced
practitioner. Started
after surg. and before
adjuvant RT and
open access followup continued for 5

Outcome
measures

specialists
and breast
care nurses,
and GP visits
using.
Economic
measures EQ-5D
HealthRelated
Quality of
Life
Questionnair
e; qualityadjusted life
year (QALY);
societal
perspective
measure of
costs
including
health care
and nonhealth care
related costs.
Improved
support and
education
provided in
both groups.
Clinicians
supported
the

Program
may be
inconvenient
for patients
to attend
and may
require
revision in

Results

Level
of evidence

• There was no signiﬁcant interaction effect between EGP
and nurse-led telephone follow-up with respect to health
related QoL.
Economic evaluation
• Hospital follow-up plus EGP yielded most quality-adjusted
life years (QALY), but was also the most costly follow-up
strategy of the study.
• Hospital follow-up plus EGP was not considered to be costeffective; nurse-led telephone follow-up plus EGP was the
preferred follow-up strategy and was conducive to cost
reductions.
• However, for patients with high levels of anxiety after
treatment, hospital follow-up plus EGP was the preferred
strategy in terms of cost effectiveness.
• The detailed cost analysis showed that health care costs
were lower if some ﬁrst year hospital follow-up visits were
replaced by nurse-led telephone follow-up. This was mostly
due to reduced costs for visits, concomitant laboratory tests
and other diagnostics.
• Mean cost differences from the societal perspective
between nurse-led telephone follow-up plus EGP and
current clinical practice (hospital follow-up), were €448 for 1
year per breast cancer patient.

EORTC
• An age factor, but not a group factor, remained in the model II
Quality of
which best described: depression and anxiety sub- scales
Life
(HADS); body image, future perspective, sexual functioning,
Questionnair systemic therapy side effects, breast symptoms and arm
e (QLQsymptoms sub- scales (QLQ- BR23); and physical
C30);
functioning, role functioning, emotional functioning,
EORTC
cognitive functioning and social functioning sub- scales
Breast
(QLQ- C30).

Author,
year,
location
Need to Study
add
design
citations
when
final

Cancer type,
treatment,
sample size
(consent
rate (CR) %)

Key components of
nurse's role/
Potential
intervention
benefits of
timeframe and
the MoC
description
years. Patients
attended a psychoeducational selfmanagement
programme "Living
with Breast Cancer"
of 4 half day
sessions and
provided with a
resource pack. Open
access to the breast
surgical services
telephone helpline
run by breast cancer
nurses. No routine
follow-up; annual
mammography
provided with results
by post and patients
can return to clinic
immediately without
GP referral.

Leahy et. Controlled
al., 2013 before and
after study

Prostate
(primary
diagnosis,

intervention
as an
acceptable
substitution
of care.
Reduced
demand on
clinic time
and
potentially
improved
efficiencies.
Patients can
attend clinic
anytime
without GP
referral,
reducing
delay.

Specialist, uroPatients
oncology CNC with reported
10 years’ experience.

Potential
deficits of
the MoC

Outcome
measures

Results

Level
of evidence

the future to
address any
changes in
evidence.
Open
access
telephone
help-line
requires
scheduled
staffing to
maintain
coverage.

Cancer
• Both age and group, plus their interaction, were found to
Module
significantly improve goodness-of- fit in a model which best
(QLQdescribes the QLQ- C30 sub- scales: fatigue, nausea and
BR23),
vomiting, pain, dyspnoea, insomnia, appetite loss,
excluding
constipation, diarrhoea and financial difficulties.
'upset by hair • Age was statistically significant with respect to the QLQloss' domain; BR23 sub- scales sexual functioning, future perspective and
Hospital
systematic therapy side effects; and the QLQ- C30 subAnxiety and
scale physical functioning. An increase in age of 1 year was
Depression
associated with an estimated: reduction of 1.01 points on
Scale
the sexual functioning sub- scale; 0.66 points increase on
(HADS)
the future perspective sub- scale; 0.68 points reduction on
the systematic therapy side effects sub- scale and a 0.42
points reduction on the physical functioning sub- scale.
• The group as a main effect was not statistically significant
with respect to any sub- scale in which the age-group
interaction was not included in the final model. The agegroup interaction was statistically significant with respect to
the QLQ-C30 diarrhoea sub- scale.
• For all sub-scales except the nausea and vomiting and
diarrhoea sub- scales (QLQ- C30) which had very low i.e.
high functionality scores, the majority of model variance
calculated using the variance partition coefficient occurred
at the patient level, with relatively low variation in scores
obtained from the same patient at different times.
• Patient age was a far more important predictor of sub- scale
scores than the assigned group. Among younger patients,
those in the control group had higher functionality, whereas
among older patients, those in the intervention group had
higher functionality.

Time
needed for
multi-

Satisfaction • 102 patients were low-intermediate risk (51 medical follow- III
with
up and 51 nurse-led follow-up) and 67 were high risk (32
Consultation medical follow-up and 35 nurse-led follow-up).

Author,
year,
location
Need to Study
add
design
citations
when
final

Cancer type,
treatment,
sample size
(consent
rate (CR) %)

Key components of
nurse's role/
Potential
intervention
benefits of
timeframe and
the MoC
description

[46],
Australia

PSA ≤20,
Gleason
score ≤7,
stage ≤2c);
RT, +/- surg.,
+/- HT;
n(C)=83,
n(I)=86
(CR=NP)

After the first medical higher
follow-up
satisfaction.
appointment at 6
weeks post RT
completion, monthly
nurse follow up
continued for 6
months. Telephone
consultations
followed evidencebased algorithms;
patients were asked
questions about wellbeing, urinary and
bowel function,
potency, fatigue and
sexual health.
Personalised
evidence-based
advice provided and
ongoing follow-up
plan documented.
CNC referred back to
GP or consultant if
required.

disciplinary
developmen
t of evidence
based
algorithms.
Support
does not
appear to be
provided for
financial,
occupational
or insurance
related
needs.

Scale;
• Low-intermediate risk patients who received nurse-led care
Distress
appeared to report higher satisfaction than low-intermediate
Thermomete risk medical follow-up patients (p=0.051). This was not
r; Expanded
statistically significant in a multivariate linear regression
Prostate
which controlled for cohort effect. Therefore, men with low
Cancer Index risk disease, followed up by nurse-led telephone service,
Composite
were as satisﬁed with their care as the equivalent group
(EPIC).
receiving conventional medical follow up.
• 11% of low-intermediate risk men who received nurse-led
care and 10% of low-intermediate risk men who received
medical follow-up were distressed (≥5/10 on distress
thermometer) (not significantly different, including when
cohort effect controlled in linear regression).
• There were no statistical signiﬁcant differences between the
risk groups across both cohorts on any of the EPIC scales.
• Men in the low-moderate risk groups reported impact of
urinary, bowel and hormonal function similar to that
published in other studies. Sexual domain scores were
much lower in this sample than other studies.
• Regardless of risk group, the majority of men had good or
very good bladder function and minimal urinary
incontinence, bowel dysfunction and sexual dysfunction.
• The high-risk groups demonstrated more marked sexual
dysfunction and more symptoms in the hormone domain.

Li et. al., RCT
2016 [47],
China

Cervical
(stage IAIIA); surg.;
n(C)=107,
n(I)=119;
(CR=92.6)

Specialist nurse.
Starting from 7 days
post-surgery and
continued for 6
months. Homebased, nurse-led
health promotion
(NLHP-HB) program

The QoL
functional
subscale
was
adversely
affected by
the
intervention.

Functional
• The intervention group at 6 months follow-up compared with II
Assessment
baseline (within groups) had significantly increased QoL
of Cancer
(p<0.001), cohesion (p<0.001), adaptability (p<0.001) and
Therapy for
female sexual function index (p<0.001). The control group
Cervical
experienced a significant decrease in the female sexual
Cancer
function index over the same period (p<0.001).
(FACT-Cx)- • The following QoL subscales were significantly increased
Chinese
(within groups) in the intervention group at 6 months follow-

The
intervention
improved
most QoL
needs
measured.

Potential
deficits of
the MoC

Outcome
measures

Results

Level
of evidence

Author,
year,
location
Need to Study
add
design
citations
when
final

Cancer type,
treatment,
sample size
(consent
rate (CR) %)

Key components of
nurse's role/
Potential
intervention
benefits of
timeframe and
the MoC
description
consisted of multidisciplinary family
care team led by
specialist nurse;
physiological pelvic
floor rehabilitation;
yoga program;
improved social
support through
education of family
and friends and
connection with
patient mentors;
fortnightly telephone
follow-up and home
visits every 2-3
months.

Malmstro RCT
m et. al.,
2016 [48],
Sweden

Oesophagus
or cardia
(C15, C16.0);
surg.;
n(C)=41,
n(I)=41
(CR=68.3)

Nurse specialised in
postoperative
oesophageal cancer
care. Started at
discharge until 6
months after
discharge. In addition

Improved
patients’
experience
of received
information.

Potential
deficits of
the MoC

Outcome
measures

Results

Level
of evidence

Intervention
may be
economicall
y and
practically
difficult to
implement.
Support
does not
appear to be
provided for
financial,
occupational
or insurance
related
needs.
Supplement
ary to usual
care, and
therefore
requires
greater
resources
for
implementati
on.

version;
up compared with baseline: social/familial (p=0.031),
Chinese
emotional (p<0.001) and cervical cancer (p<0.001).
translation of • Change scores (follow-up minus baseline) at 6 months were
the Female
significantly different between groups with a greater positive
Sexual
change in the intervention group for the following: overall
Function
QoL (p<0.001) and emotional (p<0.001), social (p<0.001)
Index (FSFI); and cervical (p<0.001) subscales; cohesion (p<0.001) and
Adaptability
adaptability (p<0.001) subscales of family function
and
(p<0.001); and female sexual function index (p<0.001). The
Cohesion
QoL functional subscale change score was negative in the
Scale,
intervention group at 6 months and was significantly
Second
different between groups (p=0.009).
Edition
• There was no significant change in the control group in the
(FACES-II).
proportion of family function change scores from baseline to
follow-up categorised as extreme low, extreme high,
balanced, and middle-range. There was a significant
change in the intervention group with an increased
proportion of extreme high and balanced types at follow-up
and decreased middle-range types.

No
improvemen
ts to QoL
and adverse
effect on
dyspnoea.
Support

EORTC
II
• The intervention group had significantly worse dyspnoea
Quality of
symptoms (QLQ-C30) during 6 months follow-up (p=0.041).
Life
There were no other significant differences between groups
Questionnair for functional or symptom QoL scales or diagnosis-specific
e (QLQQoL scales.
C30);
• At discharge, the intervention group scored significantly
Oesophagus, higher on the 'received information about treatment' and the

Author,
year,
location
Need to Study
add
design
citations
when
final

Cancer type,
treatment,
sample size
(consent
rate (CR) %)

Key components of
nurse's role/
Potential
intervention
benefits of
timeframe and
the MoC
description
to discharge
information from
nutritionist and
physiotherapist and
scheduled follow-up
with surgeon, a
nurse-led telephone
supportive care
program provided.
Pre-discharge
meeting with nurse
for patients'
questions and
concerns, and
patients provided
with oral/written
information on selfcare and life after
surgery and a followup plan. Proactive
nurse telephone
follow-up depending
on individual patient
needs (average 16
calls).

McCorkle Single-blind
et. al.,
RCT
2009 [49];
McCorkle
et al.,

Ovarian
cancer
(primary
diagnosis,
stage I-IV);
surg.,

Oncology APN and,
for highly distressed
patients, Psychiatric
Consultation–Liaison
Nurse (PCLN)(APN
in mental health

Lessened
patient
uncertainty
and, with
PCLN
added,

Potential
deficits of
the MoC

Outcome
measures

Results

Level
of evidence

does not
appear to be
provided for
occupation
or insurance
related
needs.
Supplement
ary to usual
care, and
therefore
requires
greater
resources
for
implementati
on.

Oesophago–
gastric
junction or
stomach
cancer
quality of life
module
(QLQOG25);
Perception of
cancer
information
provided
(QLQINFO25);
patient
diaries for
health care
provider
contacts;
public and
private
health
system
registry of
health care
contacts.

'written information' scale.
• During 6 months follow-up, the intervention group was
significantly more satisfied than the control group
concerning information about 'things to do to help yourself'
(p<0.001), written information (p<0.001) and the global
information score (p<0.001).
• During the 6 months follow-up, the control group was
significantly more likely to 'wish to receive more info'
(p<0.001) and at baseline, 'wish to have received less info'
(p<0.007).
• During 6 months follow-up, there were no significant
differences in the number of health care contacts (hospital
care register), private health care contacts (private care
register) and surgery related contacts between the groups.
There were no significant differences between groups in
diary recorded contacts in the first 2 or first 4 weeks.
• During the follow-up period (6 months), tumour recurrence
occurred in 24.4% of the intervention group and 22.0% of
the control group.

Support
does not
appear to be
provided for
financial,
occupational

Short-Form • 73% of patients were newly diagnosed and 27% had
II
Health
recurrent disease.
Survey (SF- • At baseline, the nursing intervention group reported
12);
significantly poorer QoL in relation to depressive symptoms
Symptom
(CES-D), uncertainty (MUIS), and mental health (SF-12).
Distress

Author,
year,
location
Need to Study
add
design
citations
when
final
2011 [50],
USA

Cancer type,
treatment,
sample size
(consent
rate (CR) %)

Key components of
nurse's role/
Potential
intervention
benefits of
timeframe and
the MoC
description

chemo.;
n(C)=60,
n(I)=63
(CR=53.0).

nursing). Postsurgery contact
consisted of 2
contacts per week for
1 month then 2 per
month up to 6
months by home and
clinic visits and
telephone calls. APN
care activities
included: postsurgery stabilization;
ADL maintenance;
symptom
management for
chemotherapy side
effects; counselling
and support;
community referrals;
and teaching selfmanagement skills.
Distressed patients
received 1-2
additional contacts
by PCLN for
psychiatric
evaluation,
identification of
resources and
referrals, and
collaborative
treatment plan
developed.

improved
some
dimensions
of QoL.

Potential
deficits of
the MoC

or insurance
related
needs.
Patient
resource
manual may
require
revision in
the future to
address any
changes in
evidence.

Outcome
measures

Scale (SDS);
Center for
Epidemiologi
cal Studies
Depression
Scale (CESD);
uncertainty
measured by
the ambiguity
subscale of
the Mishel
Uncertainty
in Illness
Scale
(MUIS);
Distress
Thermomete
r (DT).

Results

However, baseline scores for both groups were adjusted in
further model testing.
• In all models, QoL improved over time for the total sample
(all p<0.0001), except for the SF-12 mental subscale.
• The rate of improvement in uncertainty was signiﬁcantly
greater for the nursing intervention only (p=0.0006).
However, the attention control group appeared to perform
better over time in depressive symptoms (CES-D; p=0.003),
symptom distress (SDS; p=0.0021), and the physical QoL
subscale (SF-12; p=0.0019).
• Treating the PCLN component as a higher dose of the
intervention showed there was a significantly better
improvement in uncertainty (MUIS; p<0.0001) and the
mental QoL subscale (Sf-12; p=0.0023), and less
improvement over time for depressive symptoms (CES-D;
p=0.0033).
• Treating the PCLN as a separate component found that it
significantly increased the rate of improvement over time for
uncertainty (p=0.0181), symptom distress (p<0.0001), and
mental (p<0.0001) and physical QoL (p<0.0001). There was
no significant effect of the PCLN on depressive symptoms
over time.
• Co-variates which remained significant in the model building
process demonstrated that patients who were younger than
60 years, educated at a high school level or less, married,
had fewer comorbidities, and newly diagnosed with cancer
had less improvements on QoL outcomes over time.
Healthcare Utilization
• Patients who received the nursing intervention had fewer
primary care visits in 6 months after surgery (2.75 ± 2.03 vs
3.59 ± 4.66). Regression analysis confirmed patients who
received the nursing intervention had significantly less
primary care visits (β=-0.59 ± 0.16, p=0.003).

Level
of evidence

Author,
year,
location
Need to Study
add
design
citations
when
final
Meneses Single-blind
et. al.,
RCT
2007 [52];
Meneses
et.al.,
2009 [51],
USA

Cancer type,
treatment,
sample size
(consent
rate (CR) %)

Key components of
nurse's role/
Potential
intervention
benefits of
timeframe and
the MoC
description

Breast
cancer
(stage O-II,
<1 year post
diagnosis);
surg., +/chemo., +/RT, +/- HT;
n(C)=131,
n(I)=125
(CR=77.0);
n(ruralC)=26,
n(rural-I)=27
(CR(rural)=7
6.8).

Oncology nurses
trained in breast
cancer survivorship,
QoL, and education
and support. Started
Breast Cancer
Education
Intervention (BCEI)
within 1 year of
diagnosis and at
least 1 month of
treatment completion
(excluding HT) and
followed-up for 6
months. Three 60-90
minute individual
face-to-face
education and
support sessions on:
physical, emotional
and personal
changes after
treatment; health
maintenance;
relationships; work
and financial
concerns; healthy
lifestyle behaviours;
cancer surveillance
adherence;
psychological
distress; and spiritual
effects of treatment.
Written and

Intervention
improved
patient QoL.
Important
survivorship
QoL needs
addressed
by
intervention.
Oncology
nurse
provides
support and
access to
resources
after
treatment
ends.

Potential
deficits of
the MoC

Patient
resource
binder may
require
revision in
the future to
address any
changes in
evidence.
Face-to-face
consults
may be
inconvenient
to some
patients in
terms of
travel and
time.

Outcome
measures

Results

Level
of evidence

Quality of
• Overall QoL in the control group was significantly improved II
Life-Breast
from baseline to 6 months (p=0.016), between 3 and 6
Cancer
months (p=0.004) but was not improved from baseline to 3
Survivors
months (p=0.522). Overall QoL in the intervention group
Tool; FITA
was significantly improved from baseline at 3 (p<0.001) and
(Florida
at 6 months (p<0.001). The intervention group, compared
Index of
with the control group, had a significantly better
Treatment
improvement from baseline in overall QoL at 3 months
Accessibility) (p<0.001) and at 6 months (p<0.001).
• No significant interaction terms were found between the
intervention and other covariates, including time, in
Generalised Estimating Equation (GEE) models.
• GEE analysis showed significant differences in overall QOL
and psychological (p=0.0083) and social well-being
(p=0.0083) domains between groups. There were no
significant differences in physical or spiritual well-being
between groups.
Rural Analysis
• There was a significant improvement in mean overall QOL
score in the BCEI intervention group compared with the
wait-control arm over time, adjusting for baseline. The
adjusted difference in mean overall QoL scores between
experimental and control arms from 3 months to 6 months
was estimated at -0.429 (SE, 0.18; p=0.013).
• Significant improvement in mean psychological QOL score
in the BCEI intervention group compared with the waitcontrol arm over time, adjusting for baseline. The adjusted
difference in mean psychological QoL scores between
experimental and control arms from 3 months to 6 months
was estimated at -0.545 (SE, 0.26; p=0.048).
• The beneficial effect of the BCEI intervention on overall
QOL and psychological QOL score was maintained over
time; there was no significant change in scores between 3
and 6 months.
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audiotaped materials
supplemented
sessions. Monthly
follow-up sessions
for 6 months by
telephone (3x) and
face-to-face (2x).
Polinder Randomised Oesophageal
et. al.,
controlled
or gastric
2009 [53]; trial
cardia (stage
Verschuur
0-IV; surg.,
et. al.,
+/- chemo.,
2009 [58],
+-/ RT;
Netherlan
n(C)=55,
ds
n(I)=54
(CR=90.8)

Specialist nurse with
>10 years’
experience in
oncological care.
Trained in diagnosis
and treatment of
oesophageal and
gastric cardia cancer,
problems after
oesophageal
resection, medicallegal issues and
aspects of follow-up.
Three weeks after
hospital discharge
following intentionally
curative surgery, one
visit at the outpatient
clinic occurred then
nurse-led follow-up
home visits were
scheduled at 6
weeks, and 3, 6, 9
and 12 months after
recruitment. Patients
assessed for

Intervention
appeared to
be cheaper
and likely to
be more
costeffective,
particularly
early in the
timeframe;
follow-up
and
intramural
care were
areas with
largest
savings.
Patients and
carers more
satisfied
with the
various
aspects of
the
intervention.
Reduced

Support
does not
appear to be
provided for
financial,
occupational
(although
most of
sample were
retired) or
insurance
related
needs.

Quality of
Life
(EuroQol5D); EORTC
Quality of
Life
Questionnair
e (QLQC30);
oesophageal
cancer
module
(EORTC
QLQOES18);
Overall selfrated health
measured by
Visual
Analogue
Scale (EQVAS).

• Standard follow-up care visits were significantly shorter than II
visits in the nurse-led follow-up group (11 versus 43
minutes; p<0.01).
• The nurse referred 39% of patients to the outpatient clinic
for medical evaluation of specific symptoms and medical
problems.
• A similar proportion of patients in both groups developed
loco regional tumour and/or metastases at 1 year survival
(p=0.50).
• Mean body weight of patients of the standard follow-up
group significantly deteriorated during the first year after
surgery (p=0.04); whereas mean body weight in the nurseled follow-up group remained stable or slightly increased
(p=0.19).
• No significant differences were found in dysphagia scores
between the two groups; similar proportions in each group
experienced dysphagia (score 2-4) which required one or
more dilations of a benign anastomotic stricture.
• No significant differences in other physical problems
between groups.
• Improvement for all patients in health status (EQ-5D Index,
p<0.001) and self-rated health on a vertical visual analogue
scale (EQ-VAS, p<0.001).
• A significant improvement was found in the dysphagia,
eating, and indigestion scale scores (QLQ-OES18), and the
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experienced
problems and
symptoms, body
weight and the ability
to eat and/or
swallow.

length of
hospital
stay.
Patients
more likely
to utilise
general
practitioner.

Potential
deficits of
the MoC

Outcome
measures

Results

fatigue, physical, role, cognitive and social functioning
scales, and in global health (QLQ-C30).
• No significant differences in mean QoL (QLQ-C30) and
oesophageal cancer-specific QoL (QLQ-OES18) scale
scores between groups over time.
• Spouses of patients in the nurse-led follow-up group were
significantly more satisfied with the follow-up visits than
those in the standard follow-up group (p=0.03); mean
patient satisfaction was higher in the nurse-led group
compared with the standard care group but the difference
between groups was not significant (p=0.14).
• Patients and spouses in the standard follow-up group more
often indicated that visits did not fulfil their expectations
(p=0.04 and p=0.03, respectively) in terms of a systematic
follow-up schedule with diagnostic tests and/or procedures
for the early detection of recurrent malignancy.
• Patients and spouses of the nurse-led follow-up group more
frequently received advice regarding disease management
(p=0.04 and p=0.03, respectively).
• Spouses of the nurse-led follow-up group were more
satisfied they had an opportunity to ask questions (p=0.06).
Economic analysis
• Cost of nurse-led follow-up visits were significantly less than
standard follow-up (€234 vs €503, p<0.001).
• Significantly more patients in the nurse-led follow-up group
attended all 5 follow-up visits compared with standard
follow-up (82% versus 60% respectively, p=0.02)
• Mean hospital stay was significantly longer for standard
follow-up care (17.8 days versus 8.9 days, p=0.07).
• Intramural care costs were the highest cost in both followup types but were not significantly different between types.
Costs were similar between follow-up types for diagnostic
procedures, additional treatments and extramural care.
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• Total costs were lower for nurse-led care compared with
standard follow-up care (€2592 versus €3798) but due to
large variation were not statistically different (p=0.11).
• Disregarding QoL effects, there was a 91% probability that
nurse-led follow-up was cost-effective compared with
standard follow-up.
• At 4 months, there was a 98% probability that nurse-led
follow-up was cost effective compared with standard followup at €500 per point improvement in EQ-VAS (based on a
mean improvement of 14 versus 9 points for the nurse-led
and standard care groups respectively).
• At 13 months EQ-VAS scores had reduced slightly in the
nurse-led follow-up group and had remained stable in the
standard follow-up group (mean improvement 11 versus 9
points, respectively) therefore, there was a probability of
76% probability that nurse-led follow-up was cost effective
compared with standard follow-up at €4000 or more for a
one point gain on the EQ-VAS.
Sandgren RCT (3
&
groups)
McCaul,
2007 [54],
USA

Breast
(stages I—
III); surg., +/chemo., +/RT, +/- HT;
n(C)=49,
n(health
education)=7
6,
n(emotional
expression)=
89
(CR=74.1).

Oncology certified
nurses. Five weekly
30-min phone calls
starting during
adjuvant treatment,
with a 6th, follow-up
call made
approximately 3
months later. Nurse
provided either
emotional expression
therapy or health
education on topics
including:
understanding of

Almost all
patients felt
that phone
therapy was
more
convenient
attending
the clinic.

Support
does not
appear to be
provided for
financial,
occupational
or insurance
related
needs.

Functional
• At 13 months follow-up, significantly more health education II
Assessment
participants compared with emotional expression
of Cancer
participants agreed they would have liked to see their nurse
Therapy
in the past 4-5 months (48% versus 32%, p=0.035).
Scale • There were differences between the experimental groups in
General
terms of therapy process: health education sessions were a
(FACT-G);
few minutes longer than emotional expression sessions; the
reactions to
content of sessions 2-5 differed, for example, significantly
breast
more health education patients discussed treatment side
cancer;
effects (p<0.04) and significantly more emotional
Proﬁle of
expression patients discussed fears concerning recurrence
Mood States (p<0.07); and overall, more emotional expression
(POMS);
participants expressed emotionality whereas the groups did
avoidance
not differ on expression of confusion, fatigue or energy
subscale
level.
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breast cancer;
managing postsurgical changes;
understanding
treatment; managing
side effects and
fatigue; health
lifestyle; and followup review.

Potential
deficits of
the MoC

Outcome
measures

from the
Coping
Response
IndicesRevised;
perceived
stress; selfefficacy
measured
using two
subscales
from the
Cancer
Behaviour
Inventory
(CBI);
efficacy for
affect
regulation;
intrusion
subscale of
the Revised
Impact of
Events Scale
(RIES);
social
Constraint
Scale.

Results

• There was a significant effect of time (3x2 ANOVAS)
between post-test and 13 months follow-up for total QoL
and the emotional well-being sub-scale (FACT-G), and
additional breast cancer specific concerns for all women.
There were no significant effects of experimental group on
outcome nor any interaction effects between experimental
group and time; all groups improved over the 13 month
period in terms of QoL.
• Significant time effects (3x2 ANOVAS) for overall mood,
and for depression, anger, and fatigue subscales (POMS)
for all women. No significant effects of experimental group
on outcome nor any interaction effects between group and
time; all groups improved over the 13 month period in terms
of overall mood.
• Significant time effects (3x2 ANOVAS) for avoidant coping
and perceived stress with all women demonstrating
improvement from post-test to 13 month follow-up. Health
education participants reported significantly less perceived
stress than women in the emotional expression or control
groups (p=0.05).No significant between groups effects in
relation to avoidant coping nor time-group interaction effects
for either coping or perceived stress.
• Significant time effects (3x2 ANOVAS) for all participants’
confidence in their knowledge to prevent lymphedema
(p=0.005). Significantly more health education participants
reported more ways to deal with lymphedema (p=0.004).
There were no other significant time or experimental group
effects nor were there any interaction effects.
• Significant improvements over time (3x2 ANOVAS) for all
participants in intrusive thoughts (p<0.001), control over
cancer (p=0.033) and social constraints (p=0.013). No
significant between group or interaction effects.
• No significant moderators (age, education or cancer stage)
on outcome measures (overall QoL, mood, perceived
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stress, and avoidant coping) by experimental group
(ANCOVAS). Across the sample, age produced a main
effect for avoidant coping with younger women engaging in
more avoidance over time (p=0.02).
• Carers' perceptions of the patient's QoL were significantly
correlated with participants' responses (rs>0.40) and carers
perceived greater emotional distress for the patient than
reported by the patient themselves (p=0.008).
van der
RCT
Meulen
et. al.,
2013 [57];
van der
Meulen
et. al.,
2014 [55];
van der
Meulen
et. al.,
2015 [56],
Netherlan
ds

Squamous
cell
carcinoma of
the oral
cavity,
oropharynx,
hypopharynx,
or larynx
(primary
diagnosis,
stage I–II
cancer); +/surg., +/chemo., +/RT; n(C)=91,
n(I)=88
(CR=62.5)

Experienced
oncology nurses
working at the oral
maxillofacial and the
otorhinolaryngology
department. Trained
by 2 psychologists
and investigator for
intervention and 1day of standardised
intervention delivery
training. In parallel
with 2-monthly
medical check-ups
starting 6 weeks after
treatment
completion, six
counselling sessions
of 45–60 minutes for
1 year. Nurse
counselling and after
intervention (NUCAI)
consists of :
evaluating current

The
intervention
improved
depressive
symptoms,
aspects of
QoL and
some
physical
symptoms,
and some
effects were
sustained to
2 years.
Combining
the
intervention
with medical
appointment
attendance
is
convenient
to patients.

The
intervention
worsened
coughing
and did not
have an
effect on
some
symptoms
which were
problematic
to patients:
sexuality,
dry mouth
and sticky
saliva.
Nursing
resource
manual may
require
revision in
the future to
address any
changes in
evidence.

Quality of
Life
Questionnair
e (QLQC30);
EORTC
Head & Neck
Module
(QLQH&N35);
Center for
Epidemiologi
c StudiesDepression
(CES-D)
scale;
Hospital
Anxiety and
Depression
Scale
(HADS);
shortened
Dutch
version of
the Coping

One year effect
II
• At 12 months post treatment, intention to treat analysis
revealed a significant decrease in depression (CES-D) in
the intervention group compared with control. In the
depressive subgroup of patients (CES-D ≥12), the
intervention group had a significant decrease in depressive
symptoms at 12 months (p<0.05). When between group
differences were adjusted for baseline education level in
this subgroup, depressive symptoms decreased
significantly in the intervention group at 12 months from
19.0 (S.D.=7.3) to 13.8 (S.D.=10.1) but increased in the
control from 21.0 (S.D.=8.3) to 22.0 (S.D.=12.6).
• Compared with the control group, the intervention group
had significantly better reduction in physical symptoms from
baseline for: pain, swallowing and opening mouth (p<0.05).
Symptoms of dry mouth (not significant) and coughing
(p<0.05) were increased in the intervention group. In the
depressive subgroup of patients (CES-D ≥12), the
intervention group had a significantly better reduction in
physical symptoms of opening mouth (p<0.05).
• Depressive symptoms were significantly correlated with all
head and neck cancer related symptoms at baseline and 12
months. Also, depressive symptoms were significantly
correlated with changes from baseline to 12 months after
treatment for all symptoms except for dry mouth.
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mental status;
discussing current
problems;
systematically asking
about physical
problems and
functioning in six life
domains; providing
the Adjustment to
Fear, Threat or
Expectation of
Recurrence (AFTER)
intervention, if
indicated; providing
general medical
assistance and
advice, if indicated;
and referring patients
to psychological
aftercare, if indicated.
NUCAI is problem
focussed and patientled.

Potential
deficits of
the MoC

Supplement
ary to usual
care, and
therefore
requires
greater
resource
implementati
on.

Outcome
measures

Results

Inventory for Two-year effect
Stressful
• Between group differences 12 months after treatment
Situations
demonstrated a significant improvement (referenced to
(CISS); short baseline) in the intervention group for the following QLQversion of
C30 items: physical and emotional functioning and
the Social
diminished pain (p<0.05). Significant between group
Support List - differences in favour of the intervention group at 18 months
Interactions
were found for global QoL, role and emotional functioning
(SSL 12-I).
and pain (p<0.05). At 24 months, the intervention group's
emotional functioning and fatigue were significantly better
compared with the control group (p<0.05).
• Between group differences for QLQ H&N35 items at 12
months demonstrated a significant improvement
(referenced to baseline) in the intervention group compared
with the control for: pain, swallowing, social contact and
mouth opening (p<0.05); these significant effects were
sustained to 18 months, apart from social contact which
was not significantly different. At 12 months, the
intervention group reported significantly more problems with
coughing (p<0.05) than the control group. At 24 months,
there were no between group differences in any head and
neck cancer related symptoms.
• Depressive symptoms (CES-D) were significantly
diminished (p<0.05) at 12 and 18 months in the intervention
group compared with the control. At 24 months, depressive
symptoms in the intervention group were lower, but were
not significantly different compared with the control.
Moderators of psychosocial effects
• At 12 months, linear regression analysis identified the
following moderators of the effect of the intervention in the
full-case analysis (n=146; completed baseline and 12
month assessments): marital status (b=−6.75, p=0.04),
global QoL (b=−0.14, p=0.03), emotional functioning
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(b=−0.14, p=0.02), and social functioning (b=−0.13,
p=0.04).
• Post-hoc between group comparisons (n=146) found a
significant difference in favour of: married or de facto
patients compared with single patients (b=−4.25, p=0.01);
and patients with low (-1 S.D.) baseline global QoL
(b=−5.65, p=0.01), emotional functioning (b=−5.99, p=0.00),
and social functioning (b=−5.41, p=0.01) compared with
patients with mean or high (+1 S.D.) baseline scores. That
is, patients who were married/de facto, and patients with
low baseline scores on global QoL, emotional functioning,
and social functioning responded better to the intervention
than patients with high scores and who were single.
• In the intention-to-treat analyses (n=179; baseline and 3
months completed, 12 month data imputed), emotional
functioning (b=−0.14, p=0.02) and social functioning
(b=−0.15, p=0.03) were identified as moderators.
Young et. RCT
al., 2013
[59],
Australia

Colorectal
(Dukes stage
A-D, primary
diagnosis);
surg., +/chemo., +/RT;
n(C)=369,
n(I)=387
(CR=NP).

Experienced
RNs/nurse care
coordinators who
received training and
ongoing debriefing by
nurse, psychology
and medical
researchers.
Following discharge
from hospital and
supplementary to
usual care,
CONNECT
intervention
consisted of
telephone calls on

Intervention
is feasible
and
acceptable
to patients.
Intervention
began soon
after
hospital
discharge,
when needs
are high.
Slight
reduction in
unplanned
health

Supplement
ary to usual
care, and
therefore
requires
greater
resources
for
implementati
on. Support
does not
appear to be
provided for
financial,
occupational
or insurance

Supportive
Care Needs
Survey
(SCNS);
Distress
Thermomete
r tools;
Functional
Assessment
of Cancer
TherapyColorectal
(FACT-C)
quality of life
instrument;

Randomised controlled trial
II
• No significant differences between groups at 3 or 6 months
in: overall experience of cancer care coordination score,
global assessment of care coordination or quality of care;
unmet needs (SCNS-SF34); distress; overall QoL or any
subscales (FACT-C); unplanned readmissions; emergency
room presentations and proportion of Dukes C colon cancer
patients receiving adjuvant chemotherapy.
• Median scores (SCNS-SF34) were not significantly different
between groups for health system and information needs
and patient care and support needs at 3 and 6 months.
• In terms of the nurse intervention, the majority of
intervention patients very much agreed: the nurse was
caring and understanding; the assistance was satisfactory;
understandable and helpful information was provided; the
nurse understood their needs and concerns; and they had

Author,
year,
location
Need to Study
add
design
citations
when
final

Cancer type,
treatment,
sample size
(consent
rate (CR) %)

Key components of
nurse's role/
Potential
intervention
benefits of
timeframe and
the MoC
description
days 3 and 10 and
then at 1, 3 and 6
months. CONNECT
aims to improve
patients’ ability to
navigate the health
system for clinical
and supportive care,
provide information
and emotional
support, and improve
patients’ cancerrelated QOL. Each
call structured using
a standardised
checklist that covers
six areas of potential
need: common
physical,
psychosocial,
information,
supportive care, and
rehabilitation/followup needs. Needs
addressed using
detailed,
standardized clinical
protocols according
to the nature and
severity of the need
and level of clinical
risk posed.

Potential
deficits of
the MoC

service
related
utilisation
needs.
(emergency
presentation
s and
unplanned
readmissions).
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Level
of evidence

cancer care
improved confidence to self-manage health. Few patients
coordination
(<11%) very much agreed that the nurse did not have a
(total and
thorough understanding of their medical conditions or did
communicati not know about support services.
on and
• Interviews with intervention patients (n=29) identified three
navigation
groups of patients: patients who felt that the intervention did
subscales);
not influence their recovery as their local health care team
Supportive
provided information and support; a group who felt they did
Care Needs
not need the intervention because their recovery was
Survey Short straightforward and uneventful; and a third group who had
Form
acute concerns and perceived the intervention was an
(SCNSimportant service that assisted them in their postoperative
SF34).
recovery.

Abbreviations used: activities of daily living (ADL), Advanced Practice Nurse (APN), chemotherapy (chemo.), confidence interval (CI), Clinical Nurse Coordinator (CNC),
consent rate (CR), control (C), educational group program (EGP), European Organization of Research and Treatment of Cancer (EORTC), Generalised Estimating Equation

(GEE), general practitioner (GP), hormone therapy (HT), intervention (I), not provided (NP), Quality of Life Questionnaire (QLQ), Quality of Life (QoL), RCT (RCT), registered
nurse (RN), response rate (RR), radiation therapy (RT), survivorship care plan (SCP), standard deviation (S.D.), treatment summary (TS), surgery (surg.)

